Rewalk Robotics

Beleggen in aandelen beurs New York, Dow Jones index, Nasdaq-100 en S&P500
Plaats reactie
Munnybunny
Forum actieveling
Forum actieveling
Berichten: 932
Lid geworden op: 17 Sep 2014 14:20
waarderingen: 384
Contact:

Re: Rewalk Robotics

Berichtdoor Munnybunny » 13 Mar 2018 08:46

Canaccord Genuity Remains a Buy on Rewalk Robotics
By Carrie Williams

Rewalk Robotics (NASDAQ: RWLK) Canaccord Genuity analyst Kyle Rose maintained a Buy rating on Rewalk Robotics (NASDAQ: RWLK) today and set a price target of $2. The company’s shares opened today at $1.25, close to its 52-week low of $1.05.

Rose wrote:

“We maintain our BUY rating on ReWalk Robotics following Q4/17 results. ReWalk reported revenues of $1.5M, below CG/consensus of $2.1M/$1.9M. Although the shipment of 23 systems was well below our expectation for 42 systems, ReWalk sales benefited from a favorable mix of system purchases and rental conversions in the quarter. Despite the weaker than anticipated system placements, we were encouraged to see another quarter of strong demand and another positive coverage decision with reimbursement through Italy’s worker’s compensation group. While commercial unit placements continue to be lumpy Q/Q we continue to view the broader pipeline (Restore soft suit for stroke) positively in the H2/18 and beyond. Positive momentum in demand and reimbursement decisions: In Q4/17 the company placed 23 total units, down from 39 Y/Y but up Q/Q from 16.”

According to TipRanks.com, Rose is a 4-star analyst with an average return of 10.4% and a 54.2% success rate. Rose covers the Healthcare sector, focusing on stocks such as ReShape Lifesciences Inc, Obalon Therapeutics Inc, and Zimmer Biomet Holdings.

Rewalk Robotics has an analyst consensus of Moderate Buy, with a price target consensus of $2.25.

Based on Rewalk Robotics’ latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $1.52 million and GAAP net loss of $6.16 million. In comparison, last year the company earned revenue of $1.59 million and had a GAAP net loss of $8.54 million.


Munnybunny
Forum actieveling
Forum actieveling
Berichten: 932
Lid geworden op: 17 Sep 2014 14:20
waarderingen: 384
Contact:

Re: Rewalk Robotics

Berichtdoor Munnybunny » 18 Mar 2018 19:19

Man learns to walk again thanks to donation from stranger

http://www.wnem.com/story/37738077/man- ... m-stranger

Munnybunny
Forum actieveling
Forum actieveling
Berichten: 932
Lid geworden op: 17 Sep 2014 14:20
waarderingen: 384
Contact:

Re: Rewalk Robotics

Berichtdoor Munnybunny » 21 Mar 2018 17:10

Italian Workers Compensation Insurer Issues National Coverage Policy for ReWalk Exoskeletons

PR Newswire PR NewswireMarch 21, 2018
New policy for Italy follows trend of national policy programs for spinal cord injury medical device coverage

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, March 21, 2018 /PRNewswire/ -- ReWalk Robotics Ltd. (RWLK) ("ReWalk" or "the Company"), a leading manufacturer of robotic exoskeletons, today announced that INAIL, the Italian Ministry of Labor and Social Policy's statutory insurance corporation, has put in place a coverage policy that will provide exoskeleton systems for all qualifying beneficiaries. This policy, the first of its kind in Italy, will provide individuals with spinal cord injury access to obtain their own medical device so that they can stand and walk again. Importantly, the INAIL policy is now in effect. Beneficiary claims are expected to begin assessment for coverage immediately. "The INAIL policy is a milestone in the adoption of exoskeleton technology for the people of Italy, and will serve as a precedent in helping many more injured workers around the world gain access to this impactful medical device," said ReWalk CEO Larry Jasinski.

The INAIL policy is one of a series of national coverage announcements from major European national insurers, and follows the decision of the German statutory health insurance body to list the ReWalk 6.0 Exoskeleton System in the German Medical Device Directory. This trend sees insurers moving towards broad policy application for procurement and reimbursement of exoskeletons.

"We are encouraged by the series of similar decisions by insurers and other payers, and continue to work diligently with providers worldwide to develop coverage policies for spinal cord injured beneficiaries," Jasinski added.

Munnybunny
Forum actieveling
Forum actieveling
Berichten: 932
Lid geworden op: 17 Sep 2014 14:20
waarderingen: 384
Contact:

Re: Rewalk Robotics

Berichtdoor Munnybunny » 16 Mei 2018 12:04

ReWalk Robotics Receives First Tranche of $5 Million as Part of $20 Million Strategic Investment from Timwell Corporation Limited
GlobeNewswire
ReWalk to commence strategic partnership with Timwell to commercialize ReWalk products in China -- -- Ning Cong appointed to Board of Directors -- -- Establishes platform for accelerated growth in single largest stroke market